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Introduction
It is well known that pyrazoline derivatives have hypoglycemic, antibacterial, antifungal, anthelmintic, local anesthetic, and sedative activities. Parmar et al. [1] and Soni et al. [2] demonstrated that l,3,5-triphenyl-2-pyrazolines possess monoamine oxidase (MAO) inhibitory and anticonvulsant activities. In our previous studies, we synthesized several pyrazolines and tested them for their antidepressant activities and found that 1 -thiocarbamoyl-3,5-diphenyl-2-pyrazolines [3] and their condensed analogs, 8 -thiocarbamoyl-7,8-diaza-bicyclo [4.3 .0] non-6-ens [4] and 1 -N-substitued thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines [5] , have significant antidepressant activities.
In this study, e ighteen 1 -phenyl-, 1 -thiocarbamoyland l-N-substitutedthiocarbamoyl-3-phenyl-5-heteroaryl-2-pyrazoline derivatives were synthesized according to Scheme 1 and tested for their antidepressant activities by using the forced swimming test [6] . Anticonvulsant activities of the synthesized compounds were also determined by maximal electroshock (MES) and subcutaneous metrazol (scMet) tests. Seizure assays and neurotoxicity were determined by the rotarod toxicity test according to the phase I tests of the antiepileptic drug development (ADD) programme developed by the National Institute of Neurological and Communicative Disorders and Stroke [7, 8] . This programme was used for evaluation in various previous studies [9] [10] [11] [12] .
Experimental

Chemistry
All chemicals used in this study were supplied by E. Merck (Darmstadt, Germany), Aldrich Chemical (Steinheim, Germany) and Fluka (Buchs, Switzerland). Uncorrected melting points were taken in a Thomas Hoover Capillary Melting Point Apparatus (Thomas Scientific, Swedesboro, NJ, USA).
1 H-NMR spectra were recorded on a Bruker AC 80 MHz Spectrometer (Bruker BioSpin, Rheinstetten, Germany) in DMSO using TMS as internal standard. UV spectra were obtained on Shimadzu UV 160A (MeOH) (Shimadzu, Tokyo, Japan). 1R spectra were recorded in a Perkin Elmer FT-IR 1720X Spectrometer (Perkin Elmer, Boston, MA, USA) using KBr pellets. Microanalyses of compounds were performed at ATAL The Laboratory of Instrumental Analyses -The Scientific and Technical Research Council of Turkey (Ankara, Turkey).
l-Phenyl-3-hete roaryl-2-propen-l-ons (chalcones)
Chalcone derivatives were obtained from acetophenone (0.01 mol) and appropriate aldehydes (0.01 mol) by known methods [13] [14] [15] [16] . 
l,3-Diphenyl-5-heteroaryl-2-pyrazolines (I)
The solution of appropriate chalcone (0.01 mol) and phenlyhydrazine (0.02 mol) in ethanolic sodium hydroxide (0,025 mol, 20 ml) (Method A) or in glacial acetic acid (15 ml) (Method B) was refluxed for 4 h. The product was poured into ice water and the crude product which was separated out was filtered and crystallised from the proper solvent.
Thiocarbamoyl-3-phenyl-5-heteroaryl-2-pyrazolines (II)
l-Thiocarbamoyl-3-phenyl-5-heteroaryl-2-pyrazolines were obtained by heating (8 h) thiosemicarbazide (0.012 mol) with appropriate chalcone (0.01 mol) and sodium hydroxide (0.025 mol in 5 ml water) in ethanol (50 ml). The product was poured into ice water and the crude product which was separated out was filtered and crytallised from the proper solvent.
1-N-Substituted thiocarbamoyl-3-phenyl-5-heteroaryl-2-pyrazolines (III)
Hydrazine hydrate (0.02 mol) was added to an ethanolic solution of appropriate chalcone (0.01 mol, 10 ml ethanol) and refluxed for 2 h. The solvent was evaporated at reduced pressure.
The residue was dissolved in dry ether. Isothiocyanate (0.01 mole) and 4 drops of triethylamine were added and stirred for 4 h at room temperature. The mixture was evaporated to dryness and the residue was crystallized from the proper solvent.
Pharmacology
The ethics committee of Hacettepc Universiiv. School of Medicine, Ankara (Turkey) (11. 02. 2004 date 04 / 1-1 number decision) approved the animal experiments.
Antidepressant activity
Local breed, male albino mice (20 ± 2g) were used in the forced swimming test (behavioral despair test) with free access to food and water. They were housed in groups of six. On the test day, the mice were dropped one at a time into a plexiglas cylinder (10 cm diameter) containing 15 cm of water at 21-23 °C [6] . The synthesized compounds were dissolved in a 1 % aqueous solution of 'tween 80. The drugs were injected intraperitoneally in a standard volume of 0.5 ml/20 g body weight, 1 h before the test. Then, the mice were dropped individually into the plexiglas cylinder and left in the water for 6 min. After the first 2 min of the initial vigorous struggling the animals were immobile. The duration of immobility was recorded during the last 4 min of the 6-min test.
For each group of mice, the mean period of immobility and the standard error of the mean (SEM) were calculated. Dunnet's test has been used to evaluate the results, employing Pharmacological Calculation System Version 4.1 (Microcomputer Specialists, Wynnewood, PA, USA).
Anticonvulsant activity
A stimulator (Grass S88, Astro-Med. Inc. Grass Instrument Division, W. Warwick, RI, USA), constant current unit (Grass CCUIA, Grass Medical Instrument, Quincy, MA, USA), and a corneal electrode were used for the evaluation of anticonvulsant activity. All synthesized compounds were suspended in 30 % aqueous of polyethylene (PEG) 400 and administered i.p. in a volume of 0.01 mg/kg body weight to the mice. Twelve albino male mice (20 ± 2 g) were used for each compound in our laboratory according to the NINCDS-ADD [8] . Control animals received 30 % aqueous PEG 400. The compounds were tested for their anticonvulsant activity against MES and ScMet induced seizures and the rotarod toxicity test was performed for neurological toxicity according to the phase 1 tests of the ADD [8] . Pentylenetetrazole (metrazol) was a dministered subcutaneously (s.c.) on the back of the neck. Rotarod toxicity test was performed on a 1-inch diameter knurled wooden rod, rotating at 6 rpm (the rotarod used in Screening I test was made in the Hacettepe University Technical Department). Maximal Electroshock Seizure (MES) test: Maximal electroshock seizures were elicited with a 60-cycle alternating cur- 
rent of 50 mA intensity (5-7 times the intensity that is required to elicit minimal electroshock seizures) delivered via corneal electrodes for 0.2 s. A drop of 0.9 % saline was instilled in the eye prior to application of the electrodes in order to prevent the death of the animal. Abolition of the hind limb tonic extension component of the seizure was defined as protection.
Subcutaneous metrazol (ScMet) test: 85 mg/kg of metrazol (producing seizures in greater than 95 % of mice) was administered as a 0.5 % solution s.c. into the posterior midline. The animal was observed for 30 min. Failure to observe even a threshold seizure (a single episode of clonic spasms of at least 5 s duration) was defined as protection. Values represent the mean ± SEM (n = 6). * , ** Significantly different from control (Dunnet's test; p < 0.01, p < 0.05).
Neurotoxicity: The rotarod test was used to evaluate neurotoxicity. The animal was placed on a 1-inch diameter knurled wooden rod rotating at 6 rpm. Normal mice remain on a rod rotating at this speed indefinitely. Neurologic toxicity was defined as the failure of the animal to remain on the rod for 1 min.
Result and discussion
Chemistry
The formula, yields and melting points and microanalysis of the compounds are listed in Table 1 . All spectral data are in accordance with assumed structures. In the UV spectra of the compounds two absorption maxima were observed at 216-236 and 318-348.5 nm due to C= N and Ar-N-N=C-Ar groups, respectively. The IR spectra of the compounds afforded C=N stretching ( I -a,b,c and II-a,b,c , the N -H protons were not seen in the spectrum because of deuterium exchange. The N -H protons of the thiocarbamoyl group were seen at 8.38-10.12 ppm, while the aromatic protons appeared at 5.90-7.95 ppm as expected. The protons of methyl, ethyl and allyl groups and heteroaromatic rings were also observed at expected ppms (Table 3) .
Pharmacology
Antidepressant activity
The antidepressant activity of the compounds was screened by the "forced swimming test' using pargvline hydrochloride (CAS 306-07-0) and tranylcypromine sulfate (CAS 13492-01-8) as reference antidepressant d rugs. The forced swimming test is a behavioral test used to predict the efficacy of antidepressant treatments [6] . It proves effective in predicting the activity of a wide variety of antidepressant such as MAO inhibitors, atypical antidepressant and electroconvulsive shock [17] . It has good predictive value for antidepressant potency in humans [18] . As seen in Table 4 , compounds III-2a,c and III-3a,b significantly decreased the immobility time compared to controls. Compounds II-a,b,c, III-lb,lc,4a showed antidepressant activity equivalent to or higher than those of pargyline hydrochloride and tranylcypromine sulfate.
Anticonvulsant activity
The anticonvulsant activities of the compounds were initially evaluated against MES and ScMet. induced seizures using albino male mice (20 ± 2 g). The results are shown in Table 5 . According to the activity studies, 1-thiocarbamoyl derivatives II-a,b,c were found protective against MES whereas l,3-diphenyl-5-(2-furyl)-2-pyrazoline I-a in 1 -phenyl derivatives was the only compound determined to be active against MES. Some of the 1 -N-substituted-thiocarbamoyl derivatives IIIlb,c,2a,2c exhibited activity against MES and/or scMet induced seizures. Most of the 1 -N-substitutedthiocarbamo yl derivatives III-la,2b,3a,3b,3c,4a,4b,4c were found inactive. Neurotoxicity was not observed in any of the synthesized compounds which were administered to mice in the dose range of 30-300 mg/kg.
Conclusion
Among the synthesized compounds, II-a,b,c, IIIlb,lc,4a showed antidepressant activities equivalent to or higher than those of pargyline hydrochloride and tranylcypramine sulfate that were used as reference drugs. Compounds II-a,b,c were found to have significantly high anticonvulsant activity against the MES seizures. Therefore they seem to be really promising compounds for their antidepressant and anticonvulsant activities. The synthesis studies should be continued concerning this group of compounds followed by further in vivo studies. 
